Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Hypertension Reports
Published in: Current Hypertension Reports 3/2013

01-06-2013 | Blood Pressure Monitoring and Management (J Redon, Section Editor)

Ambulatory Blood Pressure Monitoring in the Prediction and Prevention of Coronary Heart Disease

Authors: Yuan-Yuan Kang, Yan Li, Ji-Guang Wang

Published in: Current Hypertension Reports | Issue 3/2013

Login to get access

Abstract

We reviewed studies of ambulatory blood pressure monitoring (ABPM) in patients with symptomatic coronary heart disease (CHD) or asymptomatic coronary lesions and in patients at high coronary risk, such as in the presence of hypertension. We identified ten cross-sectional and seven prospective studies in patients with CHD or coronary lesions. These studies showed that patients with CHD or coronary lesions often had nocturnal non-dipping or increased blood pressure variability, and might have increased risk of coronary events, due to either uncontrolled hypertension or treatment-induced hypotension identified by ABPM. We identified ten observational studies in hypertensive patients and normotensive subjects and five therapeutic trials in hypertension. These observational studies demonstrated that one or more ambulatory blood pressure components might provide predictive value for coronary events above and beyond clinic blood pressure. The therapeutic trials were less conclusive, but suggestive of additional value for the prevention of coronary events.
Literature
1.
Wang G, Li Y, Staessen JA, Lu L, Wang JG. Anthropometric and life-style factors associated with white-coat, masked, and sustained hypertension in Chinese. J Hypertens. 2007;25:2398–405.PubMedCrossRef
2.
O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers. Lancet. 1988;332:397.CrossRef
3.
Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–6.PubMedCrossRef
4.
Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5:93–8.PubMedCrossRef
5.
Li Y, Wang JG, Dolan E, Gao PJ, Guo HF, Nawrot T, et al. Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension. 2006;47:357–64.
6.
Krause T, Lovibond K, Caulfield M, McCormack T, Williams B, Guideline Development Group. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891.PubMedCrossRef
7.
Qaseem A, Fihn SD, Dallas P, Williams S, Owens DK, Shekelle P, et al. Management of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons. Ann Intern Med. 2012;157:735–43.PubMedCrossRef
8.
Caruana MP, Lahiri A, Cashman PM, Altman DG, Raftery EB. Effects of chronic congestive heart failure secondary to coronary artery disease on the circadian rhythm of blood pressure and heart rate. Am J Cardiol. 1988;62:755–9.PubMedCrossRef
9.
Mousa T, el-Sayed MA, Motawea AK, Salama MA, Elhendy A. Association of blunted nighttime blood pressure dipping with coronary artery stenosis in men. Am J Hypertens. 2004;17:977–80.PubMedCrossRef
10.
Tamura K, Tsurumi Y, Sakai M, Tanaka Y, Okano Y, Yamauchi J, et al. A possible relationship of nocturnal blood pressure variability with coronary artery disease in diabetic nephropathy. Clin Exp Hypertens. 2007;29:31–42.PubMedCrossRef
11.
Konstandonis D, Papadopoulos VP, Toumanidis ST, Papamichael CM, Kanakakis IE, Zakopoulos NA. Ability of ambulatory blood pressure monitoring and myocardial/carotid ultrasound to predict the location and the severity of coronary artery lesions in normotensive patients: a clinical study. Hypertens Res. 2007;30:741–9.PubMedCrossRef
12.
Wendelin-Saarenhovi M, Isoaho R, Hartiala J, Kivelä SL, Helenius H, Irjala K, et al. Ambulatory blood pressure: associations with coronary heart disease in the aged Finnish population. Aging Clin Exp Res. 2007;19:432–7.PubMed
13.
Ozawa M, Tamura K, Okano Y, Matsushita K, Yanagi M, Tsurumi-Ikeya Y, et al. Identification of an increased short-term blood pressure variability on ambulatory blood pressure monitoring as a coronary risk factor in diabetic hypertensives. Clin Exp Hypertens. 2009;31:259–70.PubMedCrossRef
14.
Manios E, Stamatelopoulos K, Tsivgoulis G, Barlas G, Koroboki E, Tsagalis G, et al. Time rate of blood pressure variation: a new factor associated with coronary atherosclerosis. J Hypertens. 2011;29:1109–14.PubMedCrossRef
15.
Sherwood A, Bower JK, Routledge FS, Blumenthal JA, McFetridge-Durdle JA, Newby LK, et al. Nighttime blood pressure dipping in postmenopausal women with coronary heart disease. Am J Hypertens. 2012;25:1077–82.PubMedCrossRef
16.
Turner ST, Bielak LF, Narayana AK, Sheedy 2nd PF, Schwartz GL, Peyser PA. Ambulatory blood pressure and coronary artery calcification in middle-aged and younger adults. Am J Hypertens. 2002;15:518–24.PubMedCrossRef
17.
Erdogan D, Gullu H, Caliskan M, Yildirim I, Ulus T, Bilgi M, et al. Coronary flow reserve in dipper and non-dipper hypertensive patients. Blood Press. 2005;14:345–52.PubMedCrossRef
18.
• Li Y, Wang JG. Isolated nocturnal hypertension: a disease masked in the dark. Hypertension. 2013;61:278–83. In this review article, isolated nocturnal hypertension was discussed for its definition, prevalence, reproducibility, cardiovascular risk, pathophysiology and added value to nighttime blood pressure dipping. Defining isolated nocturnal hypertension might be clinically relevant for hypertension control and cardiovascular prevention by early identifying and managing those people with elevated nighttime blood pressure and normal clinic and daytime ambulatory blood pressure but at high cardiovascular risk.PubMedCrossRef
19.
Pierdomenico SD, Bucci A, Costantini F, Lapenna D, Cuccurullo F, Mezzetti A. Circadian blood pressure changes and myocardial ischemia in hypertensive patients with coronary artery disease. J Am Coll Cardiol. 1998;31:1627–34.PubMedCrossRef
20.
Owens P, O'Brien E. Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Heart. 1999;82:477–81.PubMed
21.
Kurpesa M, Trzos E, Drozdz J, Bednarkiewicz Z, Krzemińska-Pakuła M. Myocardial ischemia and autonomic activity in dippers and non-dippers with coronary artery disease: assessment of normotensive and hypertensive patients. Int J Cardiol. 2002;83:133–42.PubMedCrossRef
22.
Bahçivan M, Gülel O, Kolbakir F. The effect of preoperative circadian blood pressure pattern on early postoperative outcomes in patients with coronary artery bypass graft surgery. Anadolu Kardiyol Derg. 2008;8:354–9.PubMed
23.
Dzielińska Z, Prejbisz A, Makowiecka-Cieśla M, Januszewicz A, Tyczyński P, Demkow M, et al. The 24-h blood pressure measurement may predict mortality and cardiovascular events in hypertensive patients with coronary artery disease. Blood Press Monit. 2009;14:99–102.PubMedCrossRef
24.
Cay S, Cagirci G, Demir AD, Balbay Y, Erbay AR, Aydogdu S, et al. Ambulatory blood pressure variability is associated with restenosis after percutaneous coronary intervention in normotensive patients. Atherosclerosis. 2011;219:951–7.PubMedCrossRef
25.
• Sobiczewski W, Wirtwein M, Gruchala M. Ambulatory systolic-diastolic pressure regression index predicts acute coronary syndromes. Blood Press. 2013 [Epub ahead of print]. In this article, ambulatory arterial stiffness index (AASI) was found to be associated with the incidence of acute coronary syndrome in a relatively large number of patients with angiographically documented coronary artery disease.
26.
Khattar RS, Swales JD, Banfield A, Dore C, Senior R, Lahiri A. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation. 1999;100:1071–6.PubMedCrossRef
27.
Verdecchia P, Schillaci G, Reboldi G, Franklin SS, Porcellati C. Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation. 2001;103:2579–84.PubMedCrossRef
28.
Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156–61.PubMedCrossRef
29.
Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens. 2006;19:243–50.PubMedCrossRef
30.
Dolan E, Thijs L, Li Y, Atkins N, McCormack P, McClory S, et al. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension. 2006;47:365–70.PubMedCrossRef
31.
Bastos JM, Bertoquini S, Silva JA, Polónia J. Relationship between ambulatory blood pressure monitoring values and future occurrence of ischemic cerebrovascular and coronary events in hypertensive patients. Rev Port Cardiol. 2006;25:305–16.PubMed
32.
Burr ML, Dolan E, O'Brien EW, O'Brien ET, McCormack P. The value of ambulatory blood pressure in older adults: the Dublin outcome study. Age Ageing. 2008;37:201–6.PubMedCrossRef
33.
Mesquita-Bastos J, Bertoquini S, Polónia J. Cardiovascular prognostic value of ambulatory blood pressure monitoring in a Portuguese hypertensive population followed up for 8.2 years. Blood Press Monit. 2010;15:240–6.PubMedCrossRef
34.
Kao YT, Huang CC, Leu HB, Wu TC, Huang PH, Lin SJ, et al. Ambulatory pulse pressure as a novel predictor for long-term prognosis in essential hypertensive patients. J Hum Hypertens. 2011;25:444–50.PubMedCrossRef
35.
Viera AJ, Lin FC, Hinderliter AL, Shimbo D, Person SD, Pletcher MJ, et al. Nighttime blood pressure dipping in young adults and coronary artery calcium 10–15 years later: the coronary artery risk development in young adults study. Hypertension. 2012;59:1157–63.PubMedCrossRef
36.
Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51:55–61.PubMedCrossRef
37.
Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2008;26:1290–9.PubMedCrossRef
38.
Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, et al. Prognostic accuracy of the day versus night ambulatory blood pressure revisited in 7458 randomly recruited subjects. Lancet. 2007;370:1219–29.PubMedCrossRef
39.
Li Y, Thijs L, Hansen TW, Kikuya M, Boggia J, Richart T, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010;55:1040–8.PubMedCrossRef
40.
Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Björklund-Bodegård K, et al. Prognostic value of short-term blood pressure variability over 24 hours in 8937 subjects from 11 populations. Hypertension. 2010;55:1049–57.PubMedCrossRef
41.
Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, et al. Prognostic value of isolated nocturnal hypertension in 8711 subjects from 10 populations. J Hypertens. 2010;28:2036–45.PubMed
42.
Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282:539–46.PubMedCrossRef
43.
Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102:1139–44.PubMedCrossRef
44.
Pedersen OL, Mancia G, Pickering T, Høegholm A, Julius S, Kjeldsen SE, et al. Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy. J Hypertens. 2007;25:707–12.PubMedCrossRef
45.
•• Dolan E, Stanton AV, Thom S, Caulfield M, Atkins N, McInnes G, et al. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens. 2009;27:876–85. This was the first therapeutic trial that collected multiple ambulatory blood pressure recordings in a relatively large number of hypertensive patients. Ambulatory blood pressure was shown to be superior to clinic blood pressure in the prediction of the composite of cardiovascular events and stroke.PubMedCrossRef
46.
Jamerson KA, Devereux R, Bakris GL, Dahlöf B, Pitt B, Velazquez EJ, et al. Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control. Hypertension. 2011;57:174–9.PubMedCrossRef
47.
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022–31.PubMedCrossRef
48.
Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895–906.PubMedCrossRef
49.
Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417–28.PubMedCrossRef
Metadata
Title
Ambulatory Blood Pressure Monitoring in the Prediction and Prevention of Coronary Heart Disease
Authors
Yuan-Yuan Kang
Yan Li
Ji-Guang Wang
Publication date
01-06-2013
Publisher
Current Science Inc.
Published in
Current Hypertension Reports / Issue 3/2013
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-013-0341-8

Other articles of this Issue 3/2013

Current Hypertension Reports 3/2013 Go to the issue

Therapeutic Trials (G Mancia, Section Editor)

Evidence of Clinically Relevant Efficacy for Dietary Supplements and Nutraceuticals

Blood Pressure Monitoring and Management (J Redon, Section Editor)

Ambulatory Blood Pressure in Stroke and Cognitive Dysfunction

Therapeutic Trials (G Mancia, Section Editor)

The Pamela Study: Main Findings and Perspectives

Hypertension and Obesity (E Reisin, Section Editor)

Pharmacologic Treatment Options for Obesity: What Is Old Is New Again

Hypertension and Obesity (E Reisin, Section Editor)

Animal Models in Obesity and Hypertension

Hypertension and Obesity (E Reisin, Section Editor)

Treatment of Obesity-Related Hypertension in Children and Adolescents
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits